Sunday, February 28, 2021

Volunteer in Covid vaccine test dies in Brazil

It is the first death reported in the various coronavirus vaccine trials taking place worldwide.

Other News

Belajar sejarah di luar buku teks

Kalau dulu kita hanya ada maklumat dari buku teks, tetapi kini apa saja maklumat boleh diperolehi melalui alam maya.

’Sindir badan’ lebih dahsyat dengan media sosial

Media sosial kini menjadi medium paling mudah untuk seseorang meluahkan perasaan sehingga mengenepikan nilai kemanusiaan, kesopanan dan kesusilaan.

Contemptuous expressions and freedom of speech

Any business which maintains internet discussion forums should be aware of and guard against the risks of liability for comments by third parties.

Online shift makes body shaming easier than ever

A psychologist warns of the negative effects of such acts while a lawyer says legal action can be taken as it is considered a criminal offence.

Kes baru Covid-19 kekal lebih 2,000, 10 lagi kematian direkodkan

3,320 pesakit pulih dan dibenarkan pulang, menjadikan jumlah keseluruhan angka sembuh 270,166 kes.

A volunteer participating in clinical trials of the Covid-19 vaccine developed by Oxford University has died in Brazil, officials announced Wednesday, though media reports said he had received a placebo, not the test vaccine.

It is the first death reported in the various coronavirus vaccine trials taking place worldwide.

However, organisers of the study said an independent review had concluded there were no safety concerns and that testing of the vaccine, developed with pharmaceutical firm AstraZeneca, would continue.

Media reports said the volunteer was a 28-year-old doctor working on the front lines of the pandemic who died of complications from Covid-19.

Brazilian newspaper Globo and international news agency Bloomberg said he was in the control group and had received a placebo rather than the test vaccine, citing sources close to the trials.

“Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford said in a statement.

AstraZeneca said medical confidentiality meant it could not give details on any individual volunteer, but that independent review had “not led to any concerns about continuation of the ongoing study”.

Brazil’s national health regulator, Anvisa, confirmed it had been notified of the case on Oct 19.

The D’Or Teaching and Research Institute (Idor), which is helping organise the tests in Brazil, said the independent review had “raised no doubts about the safety of the study, and recommended it continue”.

Oxford and AstraZeneca previously had to suspend testing of the vaccine in September when a volunteer in Britain developed an unexplained illness.

Trials resumed after British regulators and an independent review concluded the illness was not a side effect of the vaccine.

Half the volunteers in the final-stage clinical trial – a double-blind, randomised, controlled study – receive a placebo, Idor said.

Around 8,000 volunteers have been vaccinated so far in Brazil, and more than 20,000 worldwide, it said.

Study participants must be doctors, nurses or other health sector workers who come into regular contact with the virus.

The deceased volunteer was a young doctor who had been treating Covid-19 patients since March in the emergency rooms and intensive care units at two hospitals in Rio de Janeiro, Globo said.

He graduated from medical school last year, and was in good health prior to contracting the disease, family and friends told the newspaper.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

New cases stay above 2,000 as 10 more deaths reported

190 in the ICU, 99 in need of respiratory assistance.

RM10,000 fine not for all SOP offences, top cop explains

Abdul Hamid Bador says the RM10,000 compound will not be issued for offences such as failure to wear face masks.

Too soon to say if Covid-19 jabs could allow immunity passports, says Noor Hisham

The health DG says other factors including the efficacy of the vaccines administered need to be taken into consideration first.

Khairy tells why he’s not taking Pfizer jab

The minister in charge of vaccine procurement is not among the key political leaders and individuals who have been administered the Pfizer vaccine.

Daily cases back over 2,000, death toll up by 11

2,253 new cases, 3,085 recoveries.